COVID-19 patients exhibit a reduction in the absolute number of lymphocytes, including CD4+ and CD8+ T lymphocytes, which display markers related to activation or exhaustion/senescence, in addition to altered expression of master regulators and several chemokine receptors [8,9]. The gene discussed is CD8A; the disease is COVID-19.